CYTOSORBENTS CORPORATION: 10-Q filed 2020-08-04

Name: CYTOSORBENTS CORPORATION: 10-Q filed 2020-08-04
Creator: CYTOSORBENTS CORPORATION

What CYTOSORBENTS CORPORATION reported in its quarterly report filed 2020-08-04 (fiscal Q2 2020): 39 published measures, 101 facts as tagged in accession 0001104659-20-090287.

This filing

Form: 10-Q (quarterly report)
Filed: 2020-08-04
Fiscal period: fiscal Q2 2020
Accession: 0001104659-20-090287 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CYTOSORBENTS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2020-06-30	49,258,771	USD
At 2019-12-31	27,382,510	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2020-06-30	24,936,281	USD
At 2019-12-31	23,964,468	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2020-06-30	24,322,490	USD
At 2020-03-31	21,313,510	USD
At 2019-12-31	3,418,042	USD
At 2019-06-30	11,542,660	USD
At 2019-03-31	15,014,918	USD
At 2018-12-31	16,934,600	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2020-06-30	35,113,888	USD
At 2019-12-31	12,232,418	USD
At 2019-06-30	16,341,561	USD
At 2018-12-31	22,368,837	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	-2,866,956	USD	91
2020-01-01 to 2020-06-30	-6,319,735	USD	182
2019-04-01 to 2019-06-30	-3,547,405	USD	91
2019-01-01 to 2019-06-30	-8,431,232	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	-1,271,164	USD	182
2019-01-01 to 2019-06-30	-7,426,406	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	316,511	USD	182
2019-01-01 to 2019-06-30	431,042	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	25,115,143	USD	182
2019-01-01 to 2019-06-30	2,184,752	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	-1,005,920	USD	182
2019-01-01 to 2019-06-30	-801,530	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2020-06-30	-195,109,194	USD
At 2019-12-31	-188,789,459	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2020-06-30	1,952,347	USD
At 2019-12-31	1,925,325	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	1,775,632	USD	182
2019-01-01 to 2019-06-30	372,421	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	-3,297,667	USD	91
2020-01-01 to 2020-06-30	-5,776,421	USD	182
2019-04-01 to 2019-06-30	-3,629,997	USD	91
2019-01-01 to 2019-06-30	-7,915,190	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2020-06-30	41,947,959	USD
At 2019-12-31	20,901,529	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2020-06-30	15,664,335	USD
At 2019-12-31	9,936,267	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2020-06-30	2,726,614	USD
At 2019-12-31	2,039,222	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2020-06-30	3,890,392	USD
At 2019-12-31	4,467,087	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	9,842,803	USD	91
2020-01-01 to 2020-06-30	18,644,024	USD	182
2019-04-01 to 2019-06-30	8,028,157	USD	91
2019-01-01 to 2019-06-30	15,766,390	USD	181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2020-06-30	1,986,970	USD
At 2019-12-31	2,113,897	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	6,545,136	USD	91
2020-01-01 to 2020-06-30	12,867,603	USD	182
2019-04-01 to 2019-06-30	4,398,160	USD	91
2019-01-01 to 2019-06-30	7,851,200	USD	181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	6,590,903	USD	91
2020-01-01 to 2020-06-30	12,907,837	USD	182
2019-04-01 to 2019-06-30	4,506,516	USD	91
2019-01-01 to 2019-06-30	9,264,600	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	2,406,039	USD	91
2020-01-01 to 2020-06-30	4,371,324	USD	182
2019-04-01 to 2019-06-30	2,929,603	USD	91
2019-01-01 to 2019-06-30	5,348,236	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2020-06-30	36,811,870	shares
At 2019-12-31	32,616,107	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2020-06-30	218,864,425	USD
At 2019-12-31	191,648,907	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2020-06-30	530,447	USD
At 2019-12-31	525,978	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2020-06-30	1,232,388	USD
At 2019-12-31	1,070,762	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2020-06-30	1,232,388	USD
At 2019-12-31	1,070,762	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2020-06-30	15,123,924	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2020-06-30	4,126,077	USD
At 2019-12-31	3,484,894	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2020-06-30	956,709	USD
At 2019-12-31	2,088,127	USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

Period	Value	Unit	Days
At 2019-12-31	0	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	-3,472,315	USD	91
2020-01-01 to 2020-06-30	-6,315,266	USD	182
2019-04-01 to 2019-06-30	-3,797,212	USD	91
2019-01-01 to 2019-06-30	-8,374,752	USD	181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	-2,866,956	USD	91
2020-01-01 to 2020-06-30	-6,319,735	USD	182
2019-04-01 to 2019-06-30	-3,547,405	USD	91
2019-01-01 to 2019-06-30	-8,431,232	USD	181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	430,711	USD	91
2020-01-01 to 2020-06-30	-543,314	USD	182
2019-04-01 to 2019-06-30	82,592	USD	91
2019-01-01 to 2019-06-30	-516,042	USD	181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	585,828	USD	182
2019-01-01 to 2019-06-30	458,333	USD	181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	27,238,000	USD	182

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	213,000	USD	91
2020-01-01 to 2020-06-30	447,000	USD	182
2019-04-01 to 2019-06-30	230,000	USD	91
2019-01-01 to 2019-06-30	440,000	USD	181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	-659,987	USD	182
2019-01-01 to 2019-06-30	-526,547	USD	181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	-128,541	USD	182
2019-01-01 to 2019-06-30	671,490	USD	181

Inspect the source

Entity: CYTOSORBENTS CORPORATION / CIK 0001175151
Captured: 2026-09-20 07:44 UTC
SEC response SHA-256: 8bb195ec858f16302b2a8454a5ffe3eff6c1e6cd0312136a64a7a2f621b86836

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001175151.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))